Zelira Therapeutics (AU:ZLD) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Zelira Therapeutics has issued 3.5 million convertible notes valued at $1.4 million to replace a Convertible Loan Agreement. This change reflects a strategic financial move by the company to potentially strengthen its capital structure. Investors may find this development noteworthy as it could impact the company’s financial health and stock performance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
